Lorenz H. Trumper

Lorenz H. Trumper

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.

Journal: HemaSphere
Published: April 08, 2026

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Journal: Blood cancer journal
Published: January 28, 2026

Subtyping Burkitt Lymphoma by DNA Methylation.

Subtyping Burkitt Lymphoma by DNA Methylation.

Journal: Genes, chromosomes & cancer
Published: February 06, 2025

MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration.

MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration.

Journal: Genes, chromosomes & cancer
Published: November 11, 2024

Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules.

Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules.

Journal: Leukemia
Published: September 13, 2024

Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 13, 2024

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Journal: Blood cancer journal
Published: September 05, 2024

Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA.

Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA.

Journal: HemaSphere
Published: August 12, 2024

WNT5a export onto extracellular vesicles studied at single-molecule and single-vesicle resolution.

WNT5a export onto extracellular vesicles studied at single-molecule and single-vesicle resolution.

Journal: The FEBS journal
Published: March 24, 2024

Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome.

Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome.

Journal: Annals of hematology
Published: August 17, 2023

Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study.

Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study.

Journal: The Journal of hospital infection
Published: April 05, 2023

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.

Journal: HemaSphere
Published: March 07, 2023
Showing 1-12 of 149

Last Updated: 09/26/2026